Is it safe to co‑administer magnesium glycinate (120 mg elemental magnesium) with clonazepam in a patient with normal renal function (serum creatinine 77 µmol/L, eGFR 87 mL/min/1.73 m², creatinine clearance 65 mL/min)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, it is safe to take magnesium glycinate 120 mg elemental with clonazepam given your normal renal function.

With your kidney function (eGFR 87 mL/min/1.73 m², creatinine clearance 65 mL/min), you can safely take both medications together without dose adjustment or significant concern for drug interactions.

Why This Is Safe

Renal Function Assessment

Your kidney parameters indicate Stage 2 CKD at most (eGFR 60-89 mL/min), which is essentially normal kidney function with no clinically significant impairment 1. The critical threshold for magnesium safety is a creatinine clearance below 20-30 mL/min 2—you are well above this at 65 mL/min.

Magnesium Safety Profile

  • Magnesium supplements should be avoided only when creatinine clearance is <20 mL/min 2
  • Your creatinine clearance of 65 mL/min provides adequate renal excretion capacity to prevent hypermagnesemia
  • The 120 mg elemental dose is modest and commonly used in clinical practice 2
  • Systemic magnesium regulation is maintained by renal excretion, and your kidneys are functioning adequately 2

Clonazepam Considerations

The FDA label states that metabolites of clonazepam are excreted by the kidneys and caution should be exercised in patients with impaired renal function to avoid excess accumulation 3. However, this caution applies primarily to significant renal impairment—not your level of function. Your eGFR of 87 mL/min does not require clonazepam dose adjustment 3.

No Direct Drug Interaction

There is no documented pharmacokinetic or pharmacodynamic interaction between magnesium glycinate and clonazepam. One study even used magnesium sulfate infusions successfully alongside clonazepam in manic patients without adverse interactions 4. The concern with clonazepam relates to:

  • CNS depressants (opioids, alcohol, other benzodiazepines) 3
  • Not electrolyte supplements like magnesium

Monitoring Recommendations

While safe to take together, consider:

  • Monitor for excessive sedation initially, as magnesium can have mild CNS effects, though this is uncommon at your dose
  • Watch for diarrhea, the most common side effect of magnesium supplementation 2
  • No routine lab monitoring is needed for this combination at your renal function level
  • If you develop unexplained muscle weakness, confusion, or severe diarrhea, check serum magnesium levels

Common Pitfalls to Avoid

  • Don't confuse magnesium formulations: Only magnesium oxide has been studied in clinical trials for constipation; magnesium glycinate's bioavailability for other conditions is less well-characterized but appears effective for repletion 2, 5
  • Don't stop clonazepam abruptly if you experience any side effects—taper gradually under medical supervision 3
  • Avoid taking additional magnesium from other sources (antacids, laxatives) without accounting for total daily intake

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.